Clinical trials
Diabetes Mellitus, Type 1 trials in Slovenia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 4 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Ljubljana, Faculty of Medicine | 12 |
| Novo Nordisk A/S | 6 |
| Rabin Medical Center | 6 |
| University Medical Centre Ljubljana | 4 |
| Medtronic MiniMed, Inc. | 3 |
| Diamyd Therapeutics AB | 1 |
| Eli Lilly and Company | 1 |
| General and Teaching Hospital Celje | 1 |
| HealthPartners Institute | 1 |
| INNODIA iVZW | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 43 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 4 |
| Hyperglycemia | 3 |
| Hypoglycemia | 3 |
| Autoimmune Diseases | 1 |
| Diabetes Complications | 1 |
| Diabetic Ketoacidosis | 1 |
| Disease Progression | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.